WO2001021820A1 - Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene - Google Patents

Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene Download PDF

Info

Publication number
WO2001021820A1
WO2001021820A1 PCT/CA2000/001096 CA0001096W WO0121820A1 WO 2001021820 A1 WO2001021820 A1 WO 2001021820A1 CA 0001096 W CA0001096 W CA 0001096W WO 0121820 A1 WO0121820 A1 WO 0121820A1
Authority
WO
WIPO (PCT)
Prior art keywords
plant
glycerol
phosphate dehydrogenase
seq
dna sequence
Prior art date
Application number
PCT/CA2000/001096
Other languages
French (fr)
Inventor
Jitao Zou
Yangdou Wei
Cyril Periappuram
Gopalan Selvaraj
Raju Datla
Original Assignee
National Research Council Of Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Council Of Canada filed Critical National Research Council Of Canada
Priority to CA2385353A priority Critical patent/CA2385353C/en
Priority to AU73991/00A priority patent/AU7399100A/en
Priority to US10/088,079 priority patent/US7112724B1/en
Priority to EP00962133A priority patent/EP1214432A1/en
Publication of WO2001021820A1 publication Critical patent/WO2001021820A1/en
Priority to US11/122,943 priority patent/US7759547B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8273Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/18Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
    • C12P7/20Glycerol

Definitions

  • the invention relates to the field of plant genetic engineering. More specifically, the invention relates to methods for manipulating the glycerol-3-phosphate metabolism of a plant by expressing in the plant a gene for a feedback defective glycerol-3-phosphate dehydrogenase.
  • Glycerol-3-phosphate dehydrogenase (EC 1.1.1.8) is an essential enzyme for both prokaryotic and eukaryotic organisms. It catalyses the reduction of dihydroxyacetone phosphate (DHAP) to glycerol-3-phosphate (G-3-P) using NADH as reducing equivalent. Plant cells possess at least two isoforms of GPDH, one located in the plastids and the other in the cytosol 1 . The purification of the cytosolic GPDH from spinach has been reported 2 .
  • the product of the reaction catalysed by GPDH, G-3-P is a precursor for the synthesis of all glycerol lipid species, including membrane and storage lipids.
  • GPDH In addition to being essential for lipid biosynthesis, GPDH is involved in several other important biological processes. Most notably, GPDH, through consuming NADH and regenerating NAD + , plays an important role in maintaining cellular redox status.
  • the NAD + /NADH couple plays a vital role as a reservoir and carrier of reducing equivalents in cellular redox reactions. For catabolic reactions to proceed, the ratio NAD + /NADH should be high. Under normal aerobic conditions, excessive NADH is channelled into mitochondria and consumed through respiration. Under anaerobic conditions, GPDH reactions serves as a redox valve to dispose of extra reducing power. In this way, the cellular NAD+/NADH ratio can be maintained at a level allowing catabolic processes to proceed.
  • the expression of the GPDH gene is subject to redox control and induced by anoxic conditions in Saccaromyces cerevisae. Deletion of the GPD2 gene (one of the two isoforms of GPDH) results in defective growth under anaerobic conditions 4 .
  • GPDH has also been shown to play an important role in adaptation to osmotic stress in Saccaromyces cerevisae. GPDH exerts its role in osmotic and salinity stress response through its function in glycerol synthesis.
  • Glycerol is a known osmo-protectant. It is produced from G-3-P through dephosphorylation by a specific glycerol 3-phosphatase.
  • yeast cells accumulate glycerol to compensate for differences between extracellular and intracellular water potentials 5 .
  • the expression of the GPDH gene, GPD1 has been demonstrated to be osmoresponsive 6 .
  • a strain of Saccaromyces cerevisae in which the GPD1 gene has been deleted is hypersensitive to NaCF. Accumulation of glycerol as an osmoregulatory solute has been reported in some halophilic green algae including Dunaliella, Zooxanthellae, Asteromonas and Chlamydonas reinhardtii 8 .
  • the invention provides a method for expressing in a plant a heterologous glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
  • the invention provides a plant expressing a heterologous glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase.
  • the invention provides a method for producing a genetically altered plant having altered fatty acid content in its glycerolipids, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
  • the invention provides a method for producing a plant having increased glycerol and/ or glycerol-3-phosphate levels, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
  • the invention provides a method for producing a genetically altered plant having increased stress tolerance relative to the wild type, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
  • the invention provides a method for producing a genetically altered plant having increased osmotic stress tolerance relative to the wild type, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
  • the invention provides a method for increasing the cellular glycerol-3-phosphate dehydrogenase activity in a plant, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
  • the invention provides a vector for genetically transforming a plant, wherein the vector comprises a DNA encoding a protein having glycerol-3-phosphate dehydrogenase activity, and the plant, after transforming, exhibits enhanced production of glycerol and/ or glycer ol-3-phosphate .
  • FIG. 1 shows the nucleotide sequence and the deduced arnino acid sequence of the Escherichia coli gpsA2 FR gene. The point mutation is highlighted and denoted by '*';
  • FIG. 2 shows a diagram of the gpsA2 FR plant transformation vector, pGPSA-VI, not drawn to scale;
  • FIG. 3 shows a southern blot analysis with respect to the gpsA2 FR gene among the selected independent Arabidopsis thaliana transgenic lines.
  • FIG. 4 shows a northern blot analysis of gpsA2 FR gene expression in the A. thaliana transgenic lines.
  • FIG. 5 shows the leaf fatty acid profiles of the selected gpsA2 FR transgenic
  • FIG.6 shows the germination rate of the seeds produced by the selected Arabidopsis thaliana transgenic lines in Vi MS medium with or without 225 mM NaCl.
  • FIG. 7 shows the germination rate of wild type A. thaliana and transgenic line #13 seeds in Vi MS media supplemented with various concentrations of NaCl.
  • FIG. 8 shows the performance of the soil-grow transgenic plants under various degree of salinity stress as detailed in Experimental Details.
  • the heterologous enzyme that is expressed in the plant, in the method of the invention may be any glycerol-3-phosphate dehydrogenase that exhibits decreased inhibition of glycerol-3-phosphate production in the plant. Such enzymes are called feed-back defective.
  • the heterologous enzyme is a glycerol-3-phosphate dehydrogenase having a single amino acid mutation. The mutation should not greatly decrease glycerol-3-phosphate dehydrogenase activity, but should decrease inhibition of the enzyme by glycerol-3-phosphate.
  • One allele of the a E is a glycerol-3-phosphate dehydrogenase that exhibits decreased inhibition of glycerol-3-phosphate production in the plant. Such enzymes are called feed-back defective.
  • the heterologous enzyme is a glycerol-3-phosphate dehydrogenase having a single amino acid mutation. The mutation should not greatly decrease glycerol-3-phosphate dehydrogenase activity,
  • the method of the invention uses a vector comprising the gene gpsA2 FR .
  • the inventors identified a point mutation in the gspA2 FR sequence: replacement of A by C in the third nucleotide of codon 255 in gpsA.
  • the mutation results in substitution of Glu 255 (GAA) for Asp 255 (GAC) in the encoded protein.
  • the sequences of the gpsA2 FR gene and the deduced amino acid sequence of the gene are shown in FIG. 1.
  • the gene sequence is listed in SEQ ID NO: 1
  • the encoded protein is listed in SEQ ID NO: 2.
  • the vector may be any vector that is suitable for transforming the plant species used.
  • suitable vectors include pHS737, pHS738, pRD400 "; P Binl9 12 ; and pCGN3223 13 .
  • GPDH is common to the biosynthetic pathway of all plants.
  • the method of the invention can therefore be used with any plant.
  • the inventors chose to use the model plant species Arabidopsis thaliana.
  • Arabidopsis has come to be widely used as a model organism in plant molecular genetics, development, physiology and biochemistry i - 1 ⁇ .
  • This dicotyledonous plant is also closely related to Brassica crop genus and it is increasingly apparent that information concerning the genetic control of basic biological processes in Arabidopsis will be transferable to other species 17 .
  • a heterologous GPDH in a plant leads to altered fatty acid content in the triacylglycerols of the plant. It is often desirable to alter the fatty acid content of glycerolipids to achieve certain desired characteristics in oil seeds. For example, for oils destined for human consumption, it may be wished to increase unsaturated fatty acid content. For other uses, it may be desirable to increase the saturated fatty acid content.
  • plant transf ormants over-expressing the gpsA2 FR gene produce glycerolipids having an increased proportion of 16 carbon fatty acids and a concomitant decrease of 18 carbon fatty acids.
  • oil seed bearing plant is meant to encompass any plant or crop from which the oil may be isolated in marketable quantity.
  • Some plants or crops having glycerolipids with particularly interesting fatty acid composition are grown for the production of glycerolipids, even though the lipid content is low (e.g. less than 1 wt%).
  • the method of the invention may be used in such plants to modify the fatty acid content of the glycerolipid.
  • Preferred plants or crops are those having a seed lipid content of at least 1 wt%.
  • Brassica species for example mustards, canola, rape, B. campestris, B. napus, B. rapa; Cannabis sativa (Hemp, widely uses as a vegetable oil in Asia); Carthamus tinctorius (Safflower); Cocos nucifera (Coconut); Crambe abyssinica (Crambe); Cuphea species (Cuphea produce medium chain fatty acids of industrial interest); Elaeis guinensis (African oil palm); Elaeis oleifera (American oil palm); Glycine max (Soybean); Gossypium hiristum (Cotton - American); Gossypium barbadense (Cotton - Egyptian); Gossypium herbaceum (Cotton - Asiatic); Helianthus annus (Sunflower); Linum usitatissimum (Linseed or flax); Oenethera biennis
  • GPDH consumes NADH, and therefore plays an important role in maintaining a healthy cellular redox balance.
  • Stress conditions often result in perturbation of plant metabolism, and particularly redox status. Stress conditions include such things as dryness, excessive humidity, excessive heat, excessive cold, excessive sunlight, and physical damage to the plant. Such agents can lead to higher than normal levels of NADH. Excessive NADH can generate high concentrations of reactive oxygen species (ROS) that are hazardous to proteins and nucleic acids, and may even lead to cell death.
  • ROS reactive oxygen species
  • An increased GPDH activity as induced by the method of the invention, improves the capacity of plants to maintain cellular redox balance, thereby leading to an enhanced tolerance to stress.
  • osmotic stress Another type of stress suffered by plants is osmotic stress. This results when the plant is forced to grow in an environment in which the external water supply has an unusually high concentration of solute.
  • solutes include salts (particularly NaCl), however, in polluted areas, other solutes might be encountered, the method of the invention leads to increased levels of glycerol and/ or gycerol-3-phosphate in the tissues of the transformed plant.
  • Glycerol acts as an osmo-protectant, allowing the transformed plant to grow in conditions that would normally not support it.
  • a heterologous gene encoding GPDH activity can be introduced into genome of plants and expressed using conventional genetic engineering techniques.
  • Agrobacterium tumefaciens mediated transformation The most developed methodology for inserting genes into plant genomes is Agrobacterium tumefaciens mediated transformation.
  • Other techniques known in the art of introducing DNA into plants include electroporation, chemically-mediated DNA uptake, and the use of microprojectiles.
  • telomere sequences corresponding to the 3' and 5' end of the gpsA gene were synthed two primers, TTAGTGGCTGCTGCGCTC (GPSA3, SEQ ID NO: 3) and AACAATGAACCAACGTAA (GPSA5, SEQ ID NO: 4), complementary to the sequences corresponding to the 3' and 5' end of the gpsA gene, respectively.
  • PCR amplifications were performed with template DNA isolated from wild type E. coli K12 and from strain BB26R, respectively.
  • the BB26R strain harbouring the gpsA2 FR allele can be obtained according to Cronan et al.
  • the PCR products were purified with QIAquickTM PCR purification Kit (QiagenTM) and fully sequenced.
  • the sequences of gpsA (wild type) and gpsA2 FR (mutant) were compared through sequence alignment using the computer program DNAstarTM.
  • the Sacl I BamHI digested gpsA2 FR DNA fragment was subsequently inserted into the Agrobacterium binary vector pBI121 (Clontech) to replace the Sacl/ BamHI region covering the GUS gene.
  • the resultant plant transformation vector is designated as pGPSA-VI (deposited August 31, 2000, at the American Type Culture Collection, 10801 University Boulevard. Manassa, VA 20110-2209, accession no. PTA-2433).
  • the gpsA2 FR gene expression cassette in pGPSA-VI contains the gpsA2 FK -encoding region driven by the constitutive 35S promoter. Its 3' end is flanked by the NOS terminator.
  • the junction region between the 35S promoter and the gpsA2 FR encoding sequence in pGPSA-VI was confirmed through sequencing.
  • the gpsA2 FR protein will thus be expressed in all plant tissues including vegetative and reproductive (seed) tissues once the gene expression cassette is incorporated into the plant genome.
  • Arabidopsis thaliana was chosen as the plant host to test the effect of the gpsA2 FR gene since it is widely recognised as a laboratory model plant for genetic and biochemical studies. Moreover, A. thaliana in many aspects resembles Brassica napus, and is considered an oilseed plant. Genetic manipulations that are successful with A. thaliana can be applied to other species 18 . All A. thaliana control and transgenic plants were grown at the same time, in controlled growth chambers, under 16 hr fluorescent illumination (150- 200 ⁇ E.m ⁇ .sec 1 ), 8 hr dark at 22 °C, as described previously 19 .
  • Plasmid pGPSA-VI was introduced into Agrobacterium tumefaciens strain GV3101 bearing helper nopaline plasmid pMP90, via electroporation. Wild type A. thaliana plants of ecotype Columbia were grown in soil. Plants one week after bolting were vacuum-infiltrated over night with a suspension of A. tumefaciens strain GV3101 harbouring pGPSA-VI 20 .
  • Tl Dry seeds
  • Tl dry seeds
  • Tl kanamycin resistant seedlings
  • T2 kanamycin resistant seedlings
  • a typical single gene insertion event would give rise to a kanamycin resistant/ sensitive ratio of 3:1.
  • DNA was isolated from selected transgenic lines to perform Southern blot analysis with probes prepared with gpsA2 FR DNA. Total RNA was also isolated for Northern analysis to confirm the expression of the gpsA2 FR gene.
  • Lipids were isolated from developing leaves as described by Katavic et al.
  • A. thaliana ecotype Columbia (wild-type) plants and plants over-expressing the gpsA2 FR gene was measured using a protocol reported by Apse et al 22 . Pots of wild-type plants and each of the four transgenic lines (designated as #7, #13, #54 and #58) over-expressing gpsA2 FR gene were divided into five groups (labelled A through E). The plants were planted in 4' pots with each pot containing 4 plants. The plants were grown for two-weeks with nutrients-only [22 g of 20:20:20 plant nutrient (Plant Products Co. Ltd., Canada) in 80 litres of water] solutions to ensure even growth of all plants.
  • the control (A) group received the nutrient -only solution with no NaCl supplementation.
  • the remaining groups were watered with nutrient solution supplemented with NaCl.
  • the concentrations of NaCl supplementation were increased stepwise by 50 mM every 4 days for each group, to the indicated maximum: (A) 0 mM NaCl, (B) 50 mM NaCl, (C) 100 mM NaCl, (D) 150 mM NaCl, and (E) 200 mM NaCl.
  • the plants were monitored for their phenotype, flowering time etc. Seed germination assays were performed with surface sterilised
  • the gpsA2 FR gene has a point mutation that alters one amino acid Residue in the GPDH protein (gpsA2 FR )
  • the biosynthesis of G-3-P in Escherichia coli was initially investigated by Kito and Pizer 24 .
  • the gpsA locus located at minute 71 of the E. coli genetic map was determined to be the structural gene for the biosynthetic glycerol-3- phosphate dehydrogenase by Cronan and Bell 25 .
  • the nucleotide sequence and the deduced amino acid sequence of the Escherichia coli gpsA gene was reported previously 26 .
  • Biochemical studies on phospholipid biosynthesis mutants indicated that the cellular level of G-3-P must be tightly regulated Bell (1974), /. Bacteriol.117, 1065-1076].
  • coli mutant, plsB possesses a glycerol-P acyltransferase with an apparent K m for G-3-P over 10 times higher than normal.
  • revertants of the plsB mutant, BB26R were identified 27 .
  • the glycerol-3-phosphate dehydrogenase activities of these revertants were about 20-fold less sensitive to feedback inhibition by G-3-P.
  • These feedback resistant gpsA alleles were named gpsA2 FR .
  • the molecular mechanism behind the gpsA2 FR protein was unknown.
  • the gpsA2 FR gene was cloned from strain BB26R and its nucleotide sequence was determined.
  • gpsA2 FR differs from gpsA at only one nucleotide base.
  • the point mutation, a replacement of A from C at the third nucleotide of codon 255 in gpsA (FIG. 1) was founded in the gpsA2 FR gene. This point mutation resulted in a change of Glu 255 (GAA) from Asp 255 (GAC) in the glycerol-3-phosphate dehydrogenase enzyme protein.
  • the gpsA2 FR gene harbours a point mutation in comparison to the wild type gpsA gene.
  • the inventors have demonstrated that the point mutation is the reason why the GPDH enzyme is 20 time less sensitive to G-3-P feedback inhibition than the wild type. As a result, the cellular G-3-P could reach a level higher than a wild type gpsA could generate.
  • Tl transgenic plants
  • Vz MS medium kanamycin supplemented Vz MS medium.
  • the segregation ratios of the (T2) seeds from the Tl plants with regard to kanamycin resistance were investigated.
  • Transgenic line #7, #13, #54, #58 were selected for further study since segregation analysis indicated that these lines were single-insertion transgenic lines.
  • genomic DNA was isolated from T3 plant seedlings of line #7, #13, #54, #58, respectively.
  • Southern analysis of genomic DNA digested with three different restriction enzymes showed that these lines contain a single copy of the gpsA2 FR gene, and the transgene is inherently stable (FIG. 4).
  • Northern analysis with RNA extracted from these lines confirmed that the gpsA2 FR gene is expressed at a high level in these transgenic lines. Therefore, the introduction and expression of the gpsA2 FR gene into higher plants was accomplished.
  • A. thaliana gpsA2 FR transf ormants have altered fatty acid profiles
  • Total lipids were extracted from leaf tissues of transgenic plants as well as wild type control, and the fatty acid compositions were analysed using Gas Chromatography. In order to minimise any difference that might exist during plant development, care was taken to ensure all plant leaves collected were at the same developmental stage. Reproducible results were obtained with leaves collected from several wild type plants, confirming that there were no significant differences with regard to fatty acid profiles among wild type plants. Data from leaves of the A. thaliana transgenic plants, however, indicated that the gpsA2 FR gene product affects fatty acid composition. As shown in FIG.
  • gpsA2 FR transgenic plants consistently had elevated levels of 16 carbon fatty acids, and proportionately decreased level of 18 carbon fatty acid. Specifically, the transgenic plants showed about a 2-5 % increase of 16:0, and about a 1.5-3.5 % increase of 16:3 fatty acids. Concomitantly, the decrease on 18:2 and 18:3 fatty acids is at a 2-5% range (FIG. 5). Differences between the transgenic plants and the controls are also apparent if the ratios of the sum of 16-carbon (16C) fatty acid versus the sum of 18-carbon (18C) fatty acids are compared.
  • transgenic line #58, line #13 and line #54 had 16C/18C ratios of 0.53, 0.6 and 0.68, respectively, while the ratio in control plants was 0.43.
  • This phenotype is most likely a direct result of an increased supply of G-3-P generated by the high GPDH activity in the transgenic plants. It is consistent with previous report by Gardiner et al, in which an increased ratio of 16C/18C fatty acids was observed among newly synthesised fatty acids when elevated amounts of G-3-P were fed to isolated plastids 28 .
  • GPDH consumes NADH and regenerates NAD + .
  • Lowering cellular [NADH] has beneficial effects on mitochondrial respiration and energy charge.
  • GPDH participates in the control of cellular redox status, and possibly reduces the concentration of potentially damaging reactive oxygen species. Plant cells are known to go through an oxidative burst under stress conditions, often leading to cell death.
  • the enhanced salinity tolerance could be observed at different developmental stages.
  • Transgenic plant seeds germinated at the same frequency as that of the non-transgenic control plants on Vi MS medium (FIG. 6, upper panel). However, on media with added salt (Fig. 6, lower panel), the wild type germinated at only about 55%, while transgenic lines #54, #58, #7 and #13 germinated at a rate of 90%, 86%, 87% and 95%, respectively.
  • the germination frequencies of line #13 seeds were further evaluated with various NaCl concentrations. As shown in FIG.7, in all concentrations of NaCl examined, line #13 seeds consistently showed higher germination rates than that of the wild type plant seeds. The most dramatic effect was observed with 250 mM NaCl, in which less than 40% of wild type seeds germinated, while 80% of the line #13 seeds germinated. In neither cases could auxotrophic growth be established from the germinated
  • Escherichia coli BB26R with DNA insert pGPS A VI assigned PTA-2433.

Abstract

The invention provides a method for genetically transforming a plant so that it expresses a glycerol-3-phosphate dehydrogenase that is feed-back defective. The feed-back defective enzyme raises levels of glycerol and glycerol-3-phosphate in comparison to the wild type, leading to increased osmotic stress tolerance, and altered fatty acid content in glycerolipids.

Description

Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene
Field of the invention
The invention relates to the field of plant genetic engineering. More specifically, the invention relates to methods for manipulating the glycerol-3-phosphate metabolism of a plant by expressing in the plant a gene for a feedback defective glycerol-3-phosphate dehydrogenase.
Background of the invention
Glycerol-3-phosphate dehydrogenase (GPDH) (EC 1.1.1.8) is an essential enzyme for both prokaryotic and eukaryotic organisms. It catalyses the reduction of dihydroxyacetone phosphate (DHAP) to glycerol-3-phosphate (G-3-P) using NADH as reducing equivalent. Plant cells possess at least two isoforms of GPDH, one located in the plastids and the other in the cytosol1. The purification of the cytosolic GPDH from spinach has been reported2. The product of the reaction catalysed by GPDH, G-3-P, is a precursor for the synthesis of all glycerol lipid species, including membrane and storage lipids. The biosynthetic role of this enzyme in bacteria was established in vivo by the isolation of glycerol and G-3-P auxotrophs of E. coli mutant strains deficient in its activity3. These mutants could not synthesise phospholipid in the absence of supplemental G-3-P. There are no reports of plant mutants defective in GPDH activity.
In addition to being essential for lipid biosynthesis, GPDH is involved in several other important biological processes. Most notably, GPDH, through consuming NADH and regenerating NAD+, plays an important role in maintaining cellular redox status. The NAD+/NADH couple plays a vital role as a reservoir and carrier of reducing equivalents in cellular redox reactions. For catabolic reactions to proceed, the ratio NAD+/NADH should be high. Under normal aerobic conditions, excessive NADH is channelled into mitochondria and consumed through respiration. Under anaerobic conditions, GPDH reactions serves as a redox valve to dispose of extra reducing power. In this way, the cellular NAD+/NADH ratio can be maintained at a level allowing catabolic processes to proceed. The expression of the GPDH gene is subject to redox control and induced by anoxic conditions in Saccaromyces cerevisae. Deletion of the GPD2 gene (one of the two isoforms of GPDH) results in defective growth under anaerobic conditions4.
GPDH has also been shown to play an important role in adaptation to osmotic stress in Saccaromyces cerevisae. GPDH exerts its role in osmotic and salinity stress response through its function in glycerol synthesis. Glycerol is a known osmo-protectant. It is produced from G-3-P through dephosphorylation by a specific glycerol 3-phosphatase. To respond to a high external osmotic environment, yeast cells accumulate glycerol to compensate for differences between extracellular and intracellular water potentials5. The expression of the GPDH gene, GPD1, has been demonstrated to be osmoresponsive6. A strain of Saccaromyces cerevisae in which the GPD1 gene has been deleted is hypersensitive to NaCF. Accumulation of glycerol as an osmoregulatory solute has been reported in some halophilic green algae including Dunaliella, Zooxanthellae, Asteromonas and Chlamydonas reinhardtii8.
The sequence of a cDNA encoding GPDH activity has been reported for the plant Cuphea lanceolata9. The encoded protein was tentatively assigned as a cytosolic isoform.
To date, there has been no report on the genetic manipulation of plant GPDH. Summary of the invention
It is an object of the invention to provide a method for expressing in a plant a heterologous glycerol-3-phosphate dehydrogenase. It is an object of the invention to provide a plant expressing a heterologous glycerol-3-phosphate dehydrogenase, wherein the heterologous glycerol-3-phosphate dehydrogenase is subject to less feedback inhibition than wild type glycerol-3-phosphate dehydrogenase.
It is a further object of the invention to provide a genetically altered plant exhibiting altered fatty acid content in its glycerolipids.
It is a further object of the invention to provide a genetically altered plant exhibiting enhanced tolerance to osmotic stress in comparison to the wild type plant.
It is a further object of the invention to provide a genetically altered plant exhibiting increased stress tolerance in comparison to the wild type plant.
In a first aspect, the invention provides a method for expressing in a plant a heterologous glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
In a second aspect, the invention provides a plant expressing a heterologous glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase.
In a third aspect, the invention provides a method for producing a genetically altered plant having altered fatty acid content in its glycerolipids, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector. In a fourth aspect, the invention provides a method for producing a plant having increased glycerol and/ or glycerol-3-phosphate levels, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
In a fifth aspect, the invention provides a method for producing a genetically altered plant having increased stress tolerance relative to the wild type, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
In a sixth aspect, the invention provides a method for producing a genetically altered plant having increased osmotic stress tolerance relative to the wild type, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
In a seventh aspect, the invention provides a method for increasing the cellular glycerol-3-phosphate dehydrogenase activity in a plant, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
In an eighth aspect, the invention provides a vector for genetically transforming a plant, wherein the vector comprises a DNA encoding a protein having glycerol-3-phosphate dehydrogenase activity, and the plant, after transforming, exhibits enhanced production of glycerol and/ or glycer ol-3-phosphate .
Detailed description of the invention
Brief description of the drawings
The invention is illustrated with the aid of the drawings, which show:
FIG. 1 shows the nucleotide sequence and the deduced arnino acid sequence of the Escherichia coli gpsA2FR gene. The point mutation is highlighted and denoted by '*';
FIG. 2 shows a diagram of the gpsA2FR plant transformation vector, pGPSA-VI, not drawn to scale;
FIG. 3 shows a southern blot analysis with respect to the gpsA2FR gene among the selected independent Arabidopsis thaliana transgenic lines.
FIG. 4 shows a northern blot analysis of gpsA2FR gene expression in the A. thaliana transgenic lines. FIG. 5 shows the leaf fatty acid profiles of the selected gpsA2FR transgenic
Arabidopsis thaliana lines.
FIG.6 shows the germination rate of the seeds produced by the selected Arabidopsis thaliana transgenic lines in Vi MS medium with or without 225 mM NaCl. FIG. 7 shows the germination rate of wild type A. thaliana and transgenic line #13 seeds in Vi MS media supplemented with various concentrations of NaCl.
FIG. 8 shows the performance of the soil-grow transgenic plants under various degree of salinity stress as detailed in Experimental Details.
Due to its role in lipid biosynthesis as well as in the stress responses, an increased GPDH activity in plants is desirable. Transgenic approaches to over express either a plant or a non-plant GPDH gene in a plant can, in principle, be expected to increase GPDH activity. However, there are several advantages inherent in inserting a non-plant gene into a plant genome. It is well established that introducing the same plant gene back to its originating species, even under sense-orientation, can result in a decrease of the over all enzyme activity due to co-suppression. Genes of different origin (heterologous), especially those from evolutionarily distantly related species, can be expected to be free of this impediment. More importantly, proteins of identical enzymatic function are often regulated through different schemes in different species. A heterologous enzyme may potentially be free of controlling factors that inhibit the endogenous enzyme.
The heterologous enzyme that is expressed in the plant, in the method of the invention, may be any glycerol-3-phosphate dehydrogenase that exhibits decreased inhibition of glycerol-3-phosphate production in the plant. Such enzymes are called feed-back defective. In a preferred embodiment, the heterologous enzyme is a glycerol-3-phosphate dehydrogenase having a single amino acid mutation. The mutation should not greatly decrease glycerol-3-phosphate dehydrogenase activity, but should decrease inhibition of the enzyme by glycerol-3-phosphate. One allele of the a E. coli gpsA gene, gpsA2FR, has been reported to encode an altered version of the GPDH protein defective in feedback inhibition10. In a preferred embodiment, the method of the invention uses a vector comprising the gene gpsA2FR. The inventors identified a point mutation in the gspA2FR sequence: replacement of A by C in the third nucleotide of codon 255 in gpsA. The mutation results in substitution of Glu255 (GAA) for Asp255 (GAC) in the encoded protein. The sequences of the gpsA2FR gene and the deduced amino acid sequence of the gene are shown in FIG. 1. The gene sequence is listed in SEQ ID NO: 1, and the encoded protein is listed in SEQ ID NO: 2.
The vector may be any vector that is suitable for transforming the plant species used. Examples of suitable vectors include pHS737, pHS738, pRD400 "; PBinl9 12; and pCGN3223 13.
GPDH is common to the biosynthetic pathway of all plants. The method of the invention can therefore be used with any plant. The inventors chose to use the model plant species Arabidopsis thaliana. As a result of the ease with which this plant lends itself to work in both classical and molecular genetics, Arabidopsis has come to be widely used as a model organism in plant molecular genetics, development, physiology and biochemistry i -1^. This dicotyledonous plant is also closely related to Brassica crop genus and it is increasingly apparent that information concerning the genetic control of basic biological processes in Arabidopsis will be transferable to other species17.
Indeed, there are numerous examples wherein studies of the molecular biology and biochemistry of a particular metabolic pathway or developmental process and the possibility of genetically engineering a plant to bring about changes to said metabolic pathway or process, has first been tested in the model plant Arabidopsis, and then shown to yield similar phenotypes in other plants, particularly crop plants.
Expressing a heterologous GPDH in a plant, according to the method of the invention, leads to altered fatty acid content in the triacylglycerols of the plant. It is often desirable to alter the fatty acid content of glycerolipids to achieve certain desired characteristics in oil seeds. For example, for oils destined for human consumption, it may be wished to increase unsaturated fatty acid content. For other uses, it may be desirable to increase the saturated fatty acid content. The inventors have found that plant transf ormants over-expressing the gpsA2FR gene produce glycerolipids having an increased proportion of 16 carbon fatty acids and a concomitant decrease of 18 carbon fatty acids.
Due to the relationship of GPDH to glycerolipid synthesis, the method of the invention is particularly suited for use with oil seed bearing plants. The term oil seed bearing plant is meant to encompass any plant or crop from which the oil may be isolated in marketable quantity. Some plants or crops having glycerolipids with particularly interesting fatty acid composition are grown for the production of glycerolipids, even though the lipid content is low (e.g. less than 1 wt%). The method of the invention may be used in such plants to modify the fatty acid content of the glycerolipid. Preferred plants or crops are those having a seed lipid content of at least 1 wt%. Some illustrative examples of oil seed crops are as follows (trivial names are given in parentheses):
Borago ofβcinalis (Borage); Brassica species, for example mustards, canola, rape, B. campestris, B. napus, B. rapa; Cannabis sativa (Hemp, widely uses as a vegetable oil in Asia); Carthamus tinctorius (Safflower); Cocos nucifera (Coconut); Crambe abyssinica (Crambe); Cuphea species (Cuphea produce medium chain fatty acids of industrial interest); Elaeis guinensis (African oil palm); Elaeis oleifera (American oil palm); Glycine max (Soybean); Gossypium hiristum (Cotton - American); Gossypium barbadense (Cotton - Egyptian); Gossypium herbaceum (Cotton - Asiatic); Helianthus annus (Sunflower); Linum usitatissimum (Linseed or flax); Oenethera biennis (Evening primrose); Olea europea (Olive); Oryza sativa (Rice); Ricinus communis (Castor); Sesamum indicum (Sesame); Soja max (Soybean - note Glycine max is the major species); Triticum species (Wheat); and Zea maize (Corn).
GPDH consumes NADH, and therefore plays an important role in maintaining a healthy cellular redox balance. Stress conditions often result in perturbation of plant metabolism, and particularly redox status. Stress conditions include such things as dryness, excessive humidity, excessive heat, excessive cold, excessive sunlight, and physical damage to the plant. Such agents can lead to higher than normal levels of NADH. Excessive NADH can generate high concentrations of reactive oxygen species (ROS) that are hazardous to proteins and nucleic acids, and may even lead to cell death. An increased GPDH activity, as induced by the method of the invention, improves the capacity of plants to maintain cellular redox balance, thereby leading to an enhanced tolerance to stress.
Another type of stress suffered by plants is osmotic stress. This results when the plant is forced to grow in an environment in which the external water supply has an unusually high concentration of solute. The most usual solutes that are encountered include salts (particularly NaCl), however, in polluted areas, other solutes might be encountered, the method of the invention leads to increased levels of glycerol and/ or gycerol-3-phosphate in the tissues of the transformed plant. Glycerol acts as an osmo-protectant, allowing the transformed plant to grow in conditions that would normally not support it. A heterologous gene encoding GPDH activity can be introduced into genome of plants and expressed using conventional genetic engineering techniques. The most developed methodology for inserting genes into plant genomes is Agrobacterium tumefaciens mediated transformation. Other techniques known in the art of introducing DNA into plants include electroporation, chemically-mediated DNA uptake, and the use of microprojectiles.
The invention will be described in more detail with reference to the following examples. The examples serve only to illustrate the invention.
Specific embodiments a. Molecular Biological Techniques
For a general description of some of the techniques used, see Ausebel et al Current protocols in Molecular Biology, Vols 1, 2, 3, (1995) New York: Wiley, incorporated herein by reference. b. Identification of the point mutation of the gpsA2FR gene from Escherichia coli strain BB26R.
In order to investigate the structure of the gpsA2FR gene, the inventors synthesised two primers, TTAGTGGCTGCTGCGCTC (GPSA3, SEQ ID NO: 3) and AACAATGAACCAACGTAA (GPSA5, SEQ ID NO: 4), complementary to the sequences corresponding to the 3' and 5' end of the gpsA gene, respectively. PCR amplifications were performed with template DNA isolated from wild type E. coli K12 and from strain BB26R, respectively. The BB26R strain harbouring the gpsA2FR allele can be obtained according to Cronan et al. The PCR products were purified with QIAquick™ PCR purification Kit (Qiagen™) and fully sequenced. The sequences of gpsA (wild type) and gpsA2FR (mutant) were compared through sequence alignment using the computer program DNAstar™.
c. Construction of a plant transformation vector for gpsAFR
Primers GAGAGCTCTTAGTGGCTGCTGCGCTC (GPSA31, SEQ ID NO: 5) and GAAGAAGGATCCAACAATGAACCAACGTAA (GPSA51, SEQ ID NO: 6) were designed according to the sequence of gpsA2FR. At the 5' end of GPSA31, a Sacl restriction site was added, while a BamHI restriction site was added at the 5' end of GPSA5. The primers were used to perform PCR amplification of the gpsA2FR sequence. The PCR products were purified with QIAquick™ PCR purification Kit (Qiagen) and digested with Sad/ BamHI. The Sacl I BamHI digested gpsA2FR DNA fragment was subsequently inserted into the Agrobacterium binary vector pBI121 (Clontech) to replace the Sacl/ BamHI region covering the GUS gene. The resultant plant transformation vector is designated as pGPSA-VI (deposited August 31, 2000, at the American Type Culture Collection, 10801 University Blvd. Manassa, VA 20110-2209, accession no. PTA-2433). The gpsA2FR gene expression cassette in pGPSA-VI contains the gpsA2FK-encoding region driven by the constitutive 35S promoter. Its 3' end is flanked by the NOS terminator. The junction region between the 35S promoter and the gpsA2FR encoding sequence in pGPSA-VI was confirmed through sequencing. The gpsA2FR protein will thus be expressed in all plant tissues including vegetative and reproductive (seed) tissues once the gene expression cassette is incorporated into the plant genome.
d. Plant Growth Conditions
Arabidopsis thaliana was chosen as the plant host to test the effect of the gpsA2FR gene since it is widely recognised as a laboratory model plant for genetic and biochemical studies. Moreover, A. thaliana in many aspects resembles Brassica napus, and is considered an oilseed plant. Genetic manipulations that are successful with A. thaliana can be applied to other species18. All A. thaliana control and transgenic plants were grown at the same time, in controlled growth chambers, under 16 hr fluorescent illumination (150- 200 μE.m^.sec1), 8 hr dark at 22 °C, as described previously19.
e. Plant Transformation
Plasmid pGPSA-VI was introduced into Agrobacterium tumefaciens strain GV3101 bearing helper nopaline plasmid pMP90, via electroporation. Wild type A. thaliana plants of ecotype Columbia were grown in soil. Plants one week after bolting were vacuum-infiltrated over night with a suspension of A. tumefaciens strain GV3101 harbouring pGPSA-VI 20.
After infiltration, plants were grown to set seeds (Tl). Dry seeds (Tl) were harvested in bulk and screened on selective medium with 50 mg/L kanamycin. After two to three weeks on selective medium, kanamycin resistant seedlings (Tl) which appeared as green were transformed to soil to allow growing to maturity. Seeds (T2) from the Tl plants were harvested and germinated on kanamycin plates to test segregation ratios. A typical single gene insertion event would give rise to a kanamycin resistant/ sensitive ratio of 3:1. To further confirm the integration of the gpsA2FR gene, DNA was isolated from selected transgenic lines to perform Southern blot analysis with probes prepared with gpsA2FR DNA. Total RNA was also isolated for Northern analysis to confirm the expression of the gpsA2FR gene.
f . Fatty acid profile analysis Lipids were isolated from developing leaves as described by Katavic et al.
21and the fatty acid compositions were analysed by Gas Chromatography.
g. Analysis of plant tolerance towards salinity stress
The salt tolerance of A. thaliana ecotype Columbia (wild-type) plants and plants over-expressing the gpsA2FR gene was measured using a protocol reported by Apse et al 22. Pots of wild-type plants and each of the four transgenic lines (designated as #7, #13, #54 and #58) over-expressing gpsA2FR gene were divided into five groups (labelled A through E). The plants were planted in 4' pots with each pot containing 4 plants. The plants were grown for two-weeks with nutrients-only [22 g of 20:20:20 plant nutrient (Plant Products Co. Ltd., Canada) in 80 litres of water] solutions to ensure even growth of all plants. Afterwards, every alternate day over a 16-day watering regime, 25 ml of a diluted nutrient solution was applied. The control (A) group received the nutrient -only solution with no NaCl supplementation. The remaining groups were watered with nutrient solution supplemented with NaCl. The concentrations of NaCl supplementation were increased stepwise by 50 mM every 4 days for each group, to the indicated maximum: (A) 0 mM NaCl, (B) 50 mM NaCl, (C) 100 mM NaCl, (D) 150 mM NaCl, and (E) 200 mM NaCl. The plants were monitored for their phenotype, flowering time etc. Seed germination assays were performed with surface sterilised
Arabidopsis seeds of wild type and selected T3 transgenic lines sown in Petri dishes containing 20 ml half strength MS medium23, supplemented with B5 vitamins and 2% sucrose. For the salt stress germination assay, various concentrations of NaCl were added. Cultures were grown at 22 °C under fluorescent light, 16h light and 8h dark. Seed germination was recorded after a period of 10 days. The emergence of radicle and cotyledons was considered as evidence of germination.
Results
The gpsA2FR gene has a point mutation that alters one amino acid Residue in the GPDH protein (gpsA2FR)
The biosynthesis of G-3-P in Escherichia coli was initially investigated by Kito and Pizer24. The gpsA locus located at minute 71 of the E. coli genetic map was determined to be the structural gene for the biosynthetic glycerol-3- phosphate dehydrogenase by Cronan and Bell25. The nucleotide sequence and the deduced amino acid sequence of the Escherichia coli gpsA gene was reported previously26. Biochemical studies on phospholipid biosynthesis mutants indicated that the cellular level of G-3-P must be tightly regulated Bell (1974), /. Bacteriol.117, 1065-1076]. The E. coli mutant, plsB, possesses a glycerol-P acyltransferase with an apparent Km for G-3-P over 10 times higher than normal. Subsequently, revertants of the plsB mutant, BB26R, were identified27. The glycerol-3-phosphate dehydrogenase activities of these revertants were about 20-fold less sensitive to feedback inhibition by G-3-P. These feedback resistant gpsA alleles were named gpsA2FR. The molecular mechanism behind the gpsA2FR protein was unknown. The gpsA2FR gene was cloned from strain BB26R and its nucleotide sequence was determined. Sequence analysis indicated that gpsA2FR differs from gpsA at only one nucleotide base. The point mutation, a replacement of A from C at the third nucleotide of codon 255 in gpsA (FIG. 1) was founded in the gpsA2FR gene. This point mutation resulted in a change of Glu255 (GAA) from Asp255 (GAC) in the glycerol-3-phosphate dehydrogenase enzyme protein.
It has now been shown that the gpsA2FR gene harbours a point mutation in comparison to the wild type gpsA gene. The inventors have demonstrated that the point mutation is the reason why the GPDH enzyme is 20 time less sensitive to G-3-P feedback inhibition than the wild type. As a result, the cellular G-3-P could reach a level higher than a wild type gpsA could generate.
Introduction of the gpsA2FR gene into plant genomes does not af ect plant development
A large number of gpsA2FR transgenic plants were generated. These transgenic plants (Tl) were initially screened for kanamycin resistance in kanamycin supplemented Vz MS medium. All Tl transgenic plants under our growing conditions appeared indistinguishable from wild type A. thaliana control, and developed at the same pace as that of the wild type plants when transferred into soil. The fertility and the seed yield were also not affected by the transgene. It thus proved that the integration of the gpsA2FR gene did not have any adversary effect on plant growth and reproduction. The segregation ratios of the (T2) seeds from the Tl plants with regard to kanamycin resistance were investigated. Transgenic line #7, #13, #54, #58 were selected for further study since segregation analysis indicated that these lines were single-insertion transgenic lines. To further verify the incorporation of gpsAFR gene into plant genome, genomic DNA was isolated from T3 plant seedlings of line #7, #13, #54, #58, respectively. Southern analysis of genomic DNA digested with three different restriction enzymes showed that these lines contain a single copy of the gpsA2FR gene, and the transgene is inherently stable (FIG. 4). Northern analysis with RNA extracted from these lines confirmed that the gpsA2FR gene is expressed at a high level in these transgenic lines. Therefore, the introduction and expression of the gpsA2FR gene into higher plants was accomplished.
A. thaliana gpsA2FR transf ormants have altered fatty acid profiles Total lipids were extracted from leaf tissues of transgenic plants as well as wild type control, and the fatty acid compositions were analysed using Gas Chromatography. In order to minimise any difference that might exist during plant development, care was taken to ensure all plant leaves collected were at the same developmental stage. Reproducible results were obtained with leaves collected from several wild type plants, confirming that there were no significant differences with regard to fatty acid profiles among wild type plants. Data from leaves of the A. thaliana transgenic plants, however, indicated that the gpsA2FR gene product affects fatty acid composition. As shown in FIG. 5, gpsA2FR transgenic plants consistently had elevated levels of 16 carbon fatty acids, and proportionately decreased level of 18 carbon fatty acid. Specifically, the transgenic plants showed about a 2-5 % increase of 16:0, and about a 1.5-3.5 % increase of 16:3 fatty acids. Concomitantly, the decrease on 18:2 and 18:3 fatty acids is at a 2-5% range (FIG. 5). Differences between the transgenic plants and the controls are also apparent if the ratios of the sum of 16-carbon (16C) fatty acid versus the sum of 18-carbon (18C) fatty acids are compared. For example, under the growing conditions described, transgenic line #58, line #13 and line #54 had 16C/18C ratios of 0.53, 0.6 and 0.68, respectively, while the ratio in control plants was 0.43. This phenotype is most likely a direct result of an increased supply of G-3-P generated by the high GPDH activity in the transgenic plants. It is consistent with previous report by Gardiner et al, in which an increased ratio of 16C/18C fatty acids was observed among newly synthesised fatty acids when elevated amounts of G-3-P were fed to isolated plastids28.
The gpsA2FR gene improved plant stress tolerance
As stated previously, GPDH consumes NADH and regenerates NAD+. Lowering cellular [NADH] has beneficial effects on mitochondrial respiration and energy charge. GPDH participates in the control of cellular redox status, and possibly reduces the concentration of potentially damaging reactive oxygen species. Plant cells are known to go through an oxidative burst under stress conditions, often leading to cell death.
The present study revealed that the gpsA2FR transgenic plants possessed enhanced salinity tolerance. The enhanced salinity tolerance could be observed at different developmental stages. Transgenic plant seeds germinated at the same frequency as that of the non-transgenic control plants on Vi MS medium (FIG. 6, upper panel). However, on media with added salt (Fig. 6, lower panel), the wild type germinated at only about 55%, while transgenic lines #54, #58, #7 and #13 germinated at a rate of 90%, 86%, 87% and 95%, respectively. The germination frequencies of line #13 seeds were further evaluated with various NaCl concentrations. As shown in FIG.7, in all concentrations of NaCl examined, line #13 seeds consistently showed higher germination rates than that of the wild type plant seeds. The most dramatic effect was observed with 250 mM NaCl, in which less than 40% of wild type seeds germinated, while 80% of the line #13 seeds germinated. In neither cases could auxotrophic growth be established from the germinated seeds.
Wild type A. thaliana could germinate reasonably well (80%) on medium containing 175 mM NaCl. However, seedling growth and development were severely retarded. In contrast, the growth rate of the transgenic plants was substantially higher. After 6 weeks, wild type plants developed chlorosis on leaf tissues and eventually died, while under the same conditions the transgenic plants still maintain relatively healthy green leaves. Plants growing in soil were also investigated with respect to salinity tolerance. The inventors followed the treatment protocol reported by Apse et al29, designed to mimic field stress conditions. As shown in FIG. 8, the transgenic plants displayed advanced growth and developmental profiles in comparison to those of wild type plants. Most of the wild type plants repeatedly treated with 50 mM NaCl appeared severely stressed with darkened leaf colour. The same treatment did not seem to affect the growth and reproduction of the transgenic lines. Wild type plants ceased to grow and eventually died when solutions containing salt at 100 mM were applied, while the majority of the transgenic plants developed to maturity and produced seeds. When a watering regime was carried out to a salt concentration of 150 mM NaCl, the transgenic plants showed apparent stressed phenotype, but were still able to produce seeds, albeit with short siliques and very little seed yield. Plants from line # 54 exhibited the most improved salinity among the transgenic lines tested. They produced seeds even when watering reached a salt concentration of 200 mM NaCl.
AMERICAN TYPE CULTURE COLLECTION
10801 University Blvd.
Manassas, VA 20110-2209
Telephone: 7O3-365-27O0
Fax: 7O3-365-2745
FACSIMILE
Date: September 7, 2000
To: Jitao Zou
Fax Number: 306-975-4839
From: ATCC Patent Depository Number of pages: 1 (including this page)
REFERENCE: Patent Deposit
Escherichia coli BB26R with DNA insert: pGPS A VI assigned PTA-2433.
Date of Deposit: August 31, 2000 Paperwork will be forwarded to you in a few days. An invoice will be sent under separate cover. The Mastercard account of Irene Howe will be charged as follows:
Standard storage/informing $ 1,100.00
Viability Test 200.00
Total amount to PTA-2433 $ 1 ,300.00
Figure imgf000019_0001
A atent Depos tory
REFERENCES (incorporated herein by reference)
1 Gee et al, (1988) Plant Physiol. 86, 98-103; Gee et al, (1988) Plant Physiol. 87, 379-383.
2 Kirsh et al., (1992) Plant Physiol. 100, 352-359
3 Hsu and Fox (1970) /. Bacteriol. 103, 410-416; Bell (1974) /. Bacterial. 117, 1065-1076
4 Ansell et al, (1997), EMBO J. 16, 2179-2187.
5 Brown (1990), in Micorbial Water Stress Physiology, Principles and Perspectives. John Wiley & Sons, New York
6 Larsson et al, (1993), Mol. Microbiol. 10, 1101-1111.
7 Ansell et al, (1997), EMBO J. 16, 2179-2187.
8 Husic and Tolbert,(1986), Plant Physiol. 82, 594-596; Ben-Amotz and Avron, (1983), Annu Rev Microbiol. 37, 95-119.
9 Hausmann et al., (1995). In Plant Lipid Metabolism, (Kader, J.C., and Mazliak, P., eds), pp53-536, Kluwer Academic Publishers.
M Bell and Cronan (1975), /. Biol. Chem. 250, 7147-7152.
11 Datla RS, Hammerlindl JK, Panchuk B, Pelcher LE, Keller W. (1992). Modified binary plant transformation vectors with the wild-type gene encoding NPTIL; Gene 122:383-384.
12 Frisch DA, Harris-Haller LW, Yokubaitis NT, Thomas TL, Hardin SH, Hall TC. (1995). Complete sequence of the binary vector Binl9;. Plant Mol Biol 27:405-409.
13 Roesler K, Shintani D, Savage L, Boddupalli S, Ohlrogge JB (1997) Targeting of the Arabidopsis homomeric acetyl-coenzyme A carboxylase to plastids of rapeseeds;. Plant Physiol 113: 75-81
14 Meyerowitz, E.M. and Chang, C. (1985) Molecular biology of plant growth and development: Arabidopsis thaliana as an experimental system. In: Developmental Biology, Vol. 5, Plenum Press, NY., pp. 353-366. is Meyerowitz, E.M. (1987) Arabidopsis thaliana. Ann. Rev. Genet. 21: 93-111.
16 Goodman, H.M., Ecker, J.R. and Dean, C. (1995) The genome of Arabidopsis thaliana. Proc. Nat'l. Acad. Sci. USA 92: 10831-10835.
17 Lagercrantz, U., Putterill, }., Coupland, G. and Lydiate, D. (1996) Comparative mapping in Arabidopsis and Brassica, fine scale genome collinearity and congruence of genes controlling flowering. Plant J. 9: 13-20.
18 see for example: Zou et al, United States Patent No: 6,051,755, April 18, 2000.
19 Katavic et al. (1995), Plant Physiol. 108,399-409.
20 Bechtolds et al. (C.R. Acad. Sci. Paris, Sciences de la vie/Life sciences 316, 1194-1199.
21 Katavic et al. (1995) Plant Physiol. 108:399-409. Apse et al (1999) Science 285, 1256-1258. 3 Murashige and Skoog (1962), Physiol Plant 15: 473-497. J. Biol. Chem. (1969), 244, 3316-3333. s Cronan and Bell; (1974), /. Bacteriol. 118, 598-605 6 Ye and Larson (1988), /. Bacteriol, 170, 4209-4215. 7 Bell and Cronan (1975), /. Biol Chem. 250, 7147-7152. 8 Gardiner et al (1982), Plant Physiol 70, 1316-1320. 9 Apse et al (1999) Science 285, 1256-1258.

Claims

What is claimed is:
1. A method for expressing in a plant a heterologous glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
2. A method according to claim 1, wherein the glycerol-3-phosphate dehydrogenase has a single amino acid substitution which renders it feedback defective, while not significantly altering its catalytic ability.
3. A method according to claim 1, wherein the glycerol-3-phosphate dehydrogenase is gpsA2FR.
4. A method according to claim 1, wherein the DNA sequence comprises a DNA sequence encoding the amino acid sequence listed in SEQ ID NO: 2.
5. A method according to claim 1, wherein the DNA sequence encoding the glycerol-3-phosphate dehydrogenase comprises the sequence listed in SEQ ID NO: 1.
6. A method according to claim 1, wherein the glycerol-3-phosphate dehydrogenase has the amino acid sequence listed in SEQ ID NO: 2.
7. A method according to claim 1, wherein the plant is an oil seed bearing plant.
8. A method according to claim 1, wherein the plant is of the genus
Brassica.
9. A method according to claim 1, wherein the plant is Arabidopsis thaliana.
10. A plant expressing a heterologous glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase.
11. A plant according to claim 10, wherein the glycerol-3-phosphate dehydrogenase has a single amino acid substitution which renders it feedback defective, while not significantly altering its catalytic ability.
12. A plant according to claim 10, wherein the glycerol-3-phosphate dehydrogenase is gpsA2FR.
13. A plant according to claim 10, wherein the plant harbours a DNA sequence encoding the amino acid sequence listed in SEQ ID NO: 2.
14. A plant according to claim 10, wherein the plant harbours a DNA sequence as listed in SEQ ID NO: 1.
15. A plant according to claim 10, wherein the glycerol-3-phosphate dehydrogenase has the amino acid sequence listed in SEQ ID NO: 2.
16. A plant according to claim 10, wherein the plant is an oil seed bearing plant.
17. A plant according to claim 10, wherein the plant is of the genus Brassica.
18. A plant according to claim 10, wherein the plant is Arabidopsis thaliana.
19. A method for producing a genetically altered plant having altered fatty acid content in its glycerolipids, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
20. A method according to claim 19, wherein the glycerol-3-phosphate dehydrogenase has a single amino acid substitution which renders it feedback defective, while not significantly altering its catalytic ability.
21. A method according to claim 19, wherein the glycerol-3-phosphate dehydrogenase is gpsA2FR.
22. A method according to claim 19, wherein the DNA sequence comprises a DNA sequence encoding the amino acid sequence listed in SEQ ID NO: 2.
23. A method according to claim 19, wherein the DNA sequence encoding the glycerol-3-phosphate dehydrogenase comprises the sequence listed in SEQ ID NO: 1.
24. A method according to claim 19, wherein the glycerol-3-phosphate dehydrogenase has the amino acid sequence listed in SEQ ID NO: 2.
25. A method according to claim 19, wherein the plant is an oil seed bearing plant.
26. A method according to claim 19, wherein the plant is of the genus Brassica.
27. A method according to claim 19, wherein the plant is Arabidopsis thaliana.
28. A method according to claim 19, wherein the plant glycerolipid has elevated levels of C16 fatty acids.
29. A method for producing a genetically altered plant having increased stress tolerance relative to the wild type, the method comprising the steps of: providing a vector comprising a DNA sequence encoding a glycerol-3-phosphate dehydrogenase that is less sensitive to feedback inhibition than wild type glycerol-3-phosphate dehydrogenase; and transforming the plant with the vector.
30. A method according to claim 29, wherein the glycerol-3-phosphate dehydrogenase has a single amino acid substitution which renders it feedback defective, while not significantly altering its catalytic ability.
31. A method according to claim 29, wherein the glycerol-3-phosphate dehydrogenase is gpsA2FR.
32. A method according to claim 29, wherein the DNA sequence comprises a DNA sequence encoding the amino acid sequence listed in SEQ ID NO: 2.
33. A method according to claim 29, wherein the DNA sequence encoding the glycerol-3-phosphate dehydrogenase comprises the sequence listed in SEQ ID NO: 1.
34. A method according to claim 29, wherein the glycerol-3-phosphate dehydrogenase has the amino acid sequence listed in SEQ ID NO: 2.
35. A method according to claim 29, wherein the plant is an oil seed bearing plant.
36. A method according to claim 29, wherein the plant is of the genus Brassica.
37. A method according to claim 29, wherein the plant is Arabidopsis thaliana.
38. A method according to claim 29, wherein the stress is osmotic stress.
39. A vector for genetically transforming a plant, wherein the vector comprises a DNA encoding a protein having glycerol-3-phosphate dehydrogenase activity, and the plant, after transforming, exhibits enhanced biosynthesis of glycerol and/ or glycerol-3-phosphate.
PCT/CA2000/001096 1999-09-22 2000-09-21 Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene WO2001021820A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA2385353A CA2385353C (en) 1999-09-22 2000-09-21 Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene
AU73991/00A AU7399100A (en) 1999-09-22 2000-09-21 Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene
US10/088,079 US7112724B1 (en) 1999-09-22 2000-09-21 Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenese gene
EP00962133A EP1214432A1 (en) 1999-09-22 2000-09-21 Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene
US11/122,943 US7759547B2 (en) 1999-09-22 2005-05-04 Methods of producing and growing plants having improved phosphorus utilization

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15513399P 1999-09-22 1999-09-22
US60/155,133 1999-09-22

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10088079 A-371-Of-International 2000-09-21
US11/122,943 Continuation-In-Part US7759547B2 (en) 1999-09-22 2005-05-04 Methods of producing and growing plants having improved phosphorus utilization

Publications (1)

Publication Number Publication Date
WO2001021820A1 true WO2001021820A1 (en) 2001-03-29

Family

ID=22554224

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2000/001096 WO2001021820A1 (en) 1999-09-22 2000-09-21 Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene

Country Status (5)

Country Link
US (1) US7112724B1 (en)
EP (1) EP1214432A1 (en)
AU (1) AU7399100A (en)
CA (1) CA2385353C (en)
WO (1) WO2001021820A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003095655A2 (en) 2002-05-08 2003-11-20 Basf Plant Science Gmbh Methods for increasing oil content in plants
WO2004065606A2 (en) * 2003-01-22 2004-08-05 The University Of York Glycerol kinase inhibition in transgenic plant cells
WO2006125297A1 (en) * 2005-05-04 2006-11-30 National Research Council Of Canada Methods of producing and growing plants having improved phosphorus utilization
WO2007051642A1 (en) * 2005-11-07 2007-05-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for increasing the total oil content in oil plants
US8207398B2 (en) * 2005-07-18 2012-06-26 University Of Kentucky Research Foundation Plants having an enhanced resistance to necrotrophic pathogens and method of making same
CN110684749A (en) * 2019-11-13 2020-01-14 黑龙江八一农垦大学 Application of corn 3-phosphoglycerol dehydrogenase ZmGPDH4 and coding gene thereof in regulation and control of plant stress tolerance
US10724046B2 (en) 2015-09-11 2020-07-28 Kao Corporation Method of producing lipid
WO2023280175A1 (en) * 2021-07-06 2023-01-12 National Institute Of Biological Sciences, Beijing Methods for treating complex i deficiencies or cancers by modulating gro3p biosynthesis

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732155B2 (en) * 2006-12-13 2010-06-08 National Research Council Of Canada Methods for identifying lysophosphatidylcholine acyltransferases
ES2610482T3 (en) 2007-12-21 2017-04-27 National Research Council Of Canada Diacylglycerol acyltransferase 2 genes and proteins encoded by them from algae
CA2717940C (en) * 2008-03-26 2019-08-13 Zhifu Zheng Algal glycerol-3-phosphate acyltransferase
CA2724995A1 (en) * 2008-05-21 2009-11-26 National Research Council Of Canada Reduction of lyso-phosphatidylcholine acyltransferase activity
CN103911386B (en) * 2014-04-16 2016-05-11 上海市农业生物基因中心 Improve the artificial fusion of the stress tolerance of plant

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013082A1 (en) * 1991-01-16 1992-08-06 Kirin Beer Kabushiki Kaisha Chilling resistant plants and their production
WO1995006733A2 (en) * 1993-09-03 1995-03-09 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Glycerin-3-phosphate-dehydrogenase (gpdh)
WO1996038573A1 (en) * 1995-05-31 1996-12-05 National Research Council Of Canada Modification of plant lipids and seed oils utilizing yeast slc genes
EP0843007A1 (en) * 1995-07-27 1998-05-20 Kirin Beer Kabushiki Kaisha Dna strands encoding glycerol-3-phosphate acyltransferase
WO1999028480A1 (en) * 1997-12-02 1999-06-10 E.I. Du Pont De Nemours And Company Method for the production of glycerol by recombinant organisms

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7579517B2 (en) 2002-05-08 2009-08-25 Basf Plant Science Gmbh Methods for increasing oil content in plants

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013082A1 (en) * 1991-01-16 1992-08-06 Kirin Beer Kabushiki Kaisha Chilling resistant plants and their production
WO1995006733A2 (en) * 1993-09-03 1995-03-09 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Glycerin-3-phosphate-dehydrogenase (gpdh)
WO1996038573A1 (en) * 1995-05-31 1996-12-05 National Research Council Of Canada Modification of plant lipids and seed oils utilizing yeast slc genes
EP0843007A1 (en) * 1995-07-27 1998-05-20 Kirin Beer Kabushiki Kaisha Dna strands encoding glycerol-3-phosphate acyltransferase
WO1999028480A1 (en) * 1997-12-02 1999-06-10 E.I. Du Pont De Nemours And Company Method for the production of glycerol by recombinant organisms

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CLARK D ET AL: "REGULATION OF PHOSPHO LIPID BIOSYNTHESIS IN ESCHERICHIA-COLI CLONING OF THE STRUCTURAL GENE FOR THE BIOSYNTHETIC SN GLYCEROL 3 PHOSPHATE DEHYDROGENASE EC-1.1.1.8", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 255, no. 2, 1980, pages 714 - 717, XP002154728, ISSN: 0021-9258 *
EDGAR J R ET AL: "BIOSYNTHESIS IN ESCHERICHIA-COLI OF SN GLYCEROL 3 PHOSPHATE A PRECURSOR OF PHOSPHO LIPID PURIFICATION AND PHYSICAL CHARACTERIZATION OF WILD TYPE AND FEEDBACK RESISTANT FORMS OF THE BIOSYNTHETIC SN GLYCEROL 3 PHOSPHATE DEHYDROGENASE EC-1.1.1.8", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 253, no. 18, 1978, EN, pages 6348 - 6353, XP002154729, ISSN: 0021-9258 *
GEE ROBERT ET AL: "Two isoforms of dihydroxyacetone phosphate reductase from the chloroplasts of Dunaliella tertiolecta.", PLANT PHYSIOLOGY (ROCKVILLE), vol. 103, no. 1, 1993, pages 243 - 249, XP002154757, ISSN: 0032-0889 *
HAUSMANN L ET AL: "CLONING OF A CDNA CODING FOR A GLYCEROL-3-PHOSPHATE DEHYDROGENASE FROM CUPHEA LANCEOLATA", PLANT LIPID METABOLISM,XX,XX, 1995, pages 534 - 536, XP000949817 *
LARSSON K ET AL: "A GENE ENCODING SN-GLYCEROL 3-PHOSPHATE DEHYDROGENASE (NAD+) COMPLEMENTS AN OSMOSENSITIVE MUTANT OF SACCHAROMYCES CEREVISIAE", MOLECULAR MICROBIOLOGY,GB,BLACKWELL SCIENTIFIC, OXFORD, vol. 10, no. 5, 1993, pages 1101 - 1111, XP000562759, ISSN: 0950-382X *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759547B2 (en) 1999-09-22 2010-07-20 National Research Council Of Canada Methods of producing and growing plants having improved phosphorus utilization
AU2003245878B2 (en) * 2002-05-08 2008-01-24 Basf Plant Science Gmbh Methods for increasing oil content in plants
WO2003095655A3 (en) * 2002-05-08 2004-08-26 Basf Plant Science Gmbh Methods for increasing oil content in plants
WO2003095655A2 (en) 2002-05-08 2003-11-20 Basf Plant Science Gmbh Methods for increasing oil content in plants
US7579517B2 (en) 2002-05-08 2009-08-25 Basf Plant Science Gmbh Methods for increasing oil content in plants
WO2004065606A3 (en) * 2003-01-22 2004-09-16 Univ York Glycerol kinase inhibition in transgenic plant cells
WO2004065606A2 (en) * 2003-01-22 2004-08-05 The University Of York Glycerol kinase inhibition in transgenic plant cells
WO2006125297A1 (en) * 2005-05-04 2006-11-30 National Research Council Of Canada Methods of producing and growing plants having improved phosphorus utilization
US8207398B2 (en) * 2005-07-18 2012-06-26 University Of Kentucky Research Foundation Plants having an enhanced resistance to necrotrophic pathogens and method of making same
WO2007051642A1 (en) * 2005-11-07 2007-05-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for increasing the total oil content in oil plants
US10724046B2 (en) 2015-09-11 2020-07-28 Kao Corporation Method of producing lipid
CN110684749A (en) * 2019-11-13 2020-01-14 黑龙江八一农垦大学 Application of corn 3-phosphoglycerol dehydrogenase ZmGPDH4 and coding gene thereof in regulation and control of plant stress tolerance
WO2023280175A1 (en) * 2021-07-06 2023-01-12 National Institute Of Biological Sciences, Beijing Methods for treating complex i deficiencies or cancers by modulating gro3p biosynthesis

Also Published As

Publication number Publication date
AU7399100A (en) 2001-04-24
US7112724B1 (en) 2006-09-26
CA2385353A1 (en) 2001-03-29
CA2385353C (en) 2010-04-20
EP1214432A1 (en) 2002-06-19

Similar Documents

Publication Publication Date Title
Millar et al. Very‐long‐chain fatty acid biosynthesis is controlled through the expression and specificity of the condensing enzyme
Liu et al. Enhanced seed oil content by overexpressing genes related to triacylglyceride synthesis
RU2190665C2 (en) Modification of plant lipids and seed oils by yeast genes slc using
Yanai et al. Genomic organization of 251 kDa acetyl-CoA carboxylase genes in Arabidopsis: tandem gene duplication has made two differentially expressed isozymes
CA2385353C (en) Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene
AU2003245878A1 (en) Methods for increasing oil content in plants
US20020066123A1 (en) Fatty acid elongases
EP0973905B1 (en) Plant pyruvate dehydrogenase kinase gene
CN103403169A (en) Materials and method for modifying a biochemical component in a plant
US7759547B2 (en) Methods of producing and growing plants having improved phosphorus utilization
AU739905B2 (en) Transgenic plant cells and plants with modified acetyl coa production
US5859342A (en) Antisense nucleotide sequences affecting fatty acid catabolism in plants
US8148602B2 (en) Diacylglycerol acyltransferases from flax
US7214859B2 (en) Brassica pyruvate dehydrogenase kinase gene
Lee et al. Camelina cytosol-localized diacylglycerol acyltransferase 3 contributes to the accumulation of seed storage oils
CN107523584B (en) Transgenic method for improving oil content of plant nutritive tissue, expression vector and application
CN102395265A (en) Hydroperoxide lyase genes and tolerance to abiotic stress in plants
US7057091B2 (en) Brassica pyruvate dehydrogenase kinase gene
US20240110196A1 (en) Use of multigene stacking method in synthesis of nervonic acid in brassica napus
US5891726A (en) Procedure to increase the seed productivity of plants and to accelerate the growth of plants by means of an additional plastidic pyruvate, phosphate dikinase
JP2001506123A (en) Transgenic plant cells and transgenic plants with increased glycolytic efficiency
US20050170478A1 (en) Expression of phospholipid:diacylglycerine acyltranssferase (pdat) for the production of plant storage lipids with polyunsaturated fatty acids
CN102070708A (en) Protein BnL1L related to seed fatty acid synthesis as well as encoding gene and applications thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2385353

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 73991/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000962133

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000962133

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10088079

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2000962133

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP